Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Immunosuppressive effects in infants treated with corticosteroids for infantile hemangiomas.

Kelly ME, Juern AM, Grossman WJ, Schauer DW, Drolet BA.

Arch Dermatol. 2010 Jul;146(7):767-74. doi: 10.1001/archdermatol.2010.90. Epub 2010 May 17.

PMID:
20479291
2.

Propranolol in the management of airway infantile hemangiomas.

Rosbe KW, Suh KY, Meyer AK, Maguiness SM, Frieden IJ.

Arch Otolaryngol Head Neck Surg. 2010 Jul;136(7):658-65. doi: 10.1001/archoto.2010.92.

PMID:
20644059
3.

Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial.

Pope E, Krafchik BR, Macarthur C, Stempak D, Stephens D, Weinstein M, Ho N, Baruchel S.

Pediatrics. 2007 Jun;119(6):e1239-47. Epub 2007 May 7.

PMID:
17485449
4.

Methotrexate therapy in asthma increases T cell susceptibility to corticosteroid inhibition.

Corrigan CJ, Shiner R, Shakur BH, Ind PW.

Clin Exp Allergy. 2003 Aug;33(8):1090-6.

PMID:
12911783
5.

Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis.

Price CJ, Lattouf C, Baum B, McLeod M, Schachner LA, Duarte AM, Connelly EA.

Arch Dermatol. 2011 Dec;147(12):1371-6. doi: 10.1001/archdermatol.2011.203. Epub 2011 Aug 15.

PMID:
21844428
6.

Combination of oral corticosteroids and polidocanol sclerotherapy in the management of infantile hemangiomas.

Grover C, Arora P, Kedar A, Pal P, Lal B.

Dermatol Surg. 2010 Dec;36(12):2030-6. doi: 10.1111/j.1524-4725.2010.01760.x. Epub 2010 Oct 11.

PMID:
21040124
7.
8.

Treatment of hemangiomas of infants with high doses of prednisone.

Sadan N, Wolach B.

J Pediatr. 1996 Jan;128(1):141-6.

PMID:
8551406
9.

Growth, bone mineral accretion, and adrenal function in glucocorticoid-treated infants with hemangiomas-- a retrospective study.

Lomenick JP, Backeljauw PF, Lucky AW.

Pediatr Dermatol. 2006 Mar-Apr;23(2):169-74.

PMID:
16650230
10.

Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.

Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT.

Laryngoscope. 2010 Apr;120(4):676-81. doi: 10.1002/lary.20807.

PMID:
20112413
11.

Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas.

George ME, Sharma V, Jacobson J, Simon S, Nopper AJ.

Arch Dermatol. 2004 Aug;140(8):963-9.

PMID:
15313812
12.

Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma.

Aly MM, Hamza AF, Abdel Kader HM, Saafan HA, Ghazy MS, Ragab IA.

Eur J Pediatr. 2015 Nov;174(11):1503-9. doi: 10.1007/s00431-015-2561-1. Epub 2015 May 16.

PMID:
25982338
14.
15.

Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who receive dexamethasone for chronic lung disease.

Robinson MJ, Heal C, Gardener E, Powell P, Sims DG.

Pediatrics. 2004 Apr;113(4):733-7.

PMID:
15060220
16.

Corticosteroids therapy in the management of infantile cutaneous hemangiomas.

Jalil S, Akhtar J, Ahmed S.

J Coll Physicians Surg Pak. 2006 Oct;16(10):662-5.

PMID:
17007757
17.

Complications of systemic corticosteroid therapy for problematic hemangioma.

Boon LM, MacDonald DM, Mulliken JB.

Plast Reconstr Surg. 1999 Nov;104(6):1616-23.

PMID:
10541160
18.
19.
20.

Preterm infants' T cell responses to inactivated poliovirus vaccine.

Klein NP, Gans HA, Sung P, Yasukawa LL, Johnson J, Sarafanov A, Chumakov K, Hansen J, Black S, Dekker CL.

J Infect Dis. 2010 Jan 15;201(2):214-22. doi: 10.1086/649590.

PMID:
20017631

Supplemental Content

Support Center